Huadong Medicine's subsidiary, Xinkelimayxue, has received acceptance for a change registration application for its medical device, Ellansé® S-type. This application seeks to expand the approved uses of the injectable poly-L-lactic acid facial filler to include implantation in the subcutaneous or periosteal layers of the forehead for correcting moderate to severe forehead contour defects. The company also announced the establishment of Zhejiang Wuju Neng Supply Chain Management Co., Ltd., with a registered capital of 100 million RMB, focusing on supply chain management and sales. AI
RANK_REASON This is a product update for a medical device, not a core AI development.
- Ellansé® S-type
- National Medical Products Administration
- Xinkelimayxue (Hangzhou) Supply Chain Management Co., Ltd.
- Zhejiang Wuju Neng Supply Chain Management Co., Ltd.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →